Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
scientific article published on 08 June 2020
Author/s
author: Giovanni Caocci, Elisabetta Abruzzese, Francesco Albano, Mario Tiribelli, Massimiliano Bonifacio, Sara Galimberti, Nicola Sgherza, Fabio Stagno, Immacolata Attolico, Gianni Binotto, Luigi Scaffidi, Daniele Cattaneo, Mario Annunziata, Giorgio La Nasa, Rossella Stella, Antonella Gozzini, Patrizia Pregno, Luigiana Luciano, Massimo Breccia, Ester Maria Orlandi, Isabella Capodanno, Claudia Baratè, Fiorenza De Gregorio, Chiara Elena, Francesca Pirillo, Malgorzata Monika Trawinska, Fausto Castagnetti, Emilia Scalzulli, Fabio Efficace, Claudio Fozza, Debora Luzi, Maria Pina Simula
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.